Science Explorer Back to mapMap
Discussion
Company · Rockville · United States

OncoImmune (United States)

oncoimmune.comROR OpenAlex
Research works
67
▲ 24% vs 2018-21
Citations
1.6k
23.8 per fractional work
Top-10% rate
9.6%
all institutions 10.0%
Open access
38%
world 40%
International
15%
world 18%
OncoImmune (United States)

Not ranked overall: OncoImmune (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does OncoImmune (United States) work in?

In 2022-now, 54% of research at OncoImmune (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Medicine (37%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (25%). It does 2.5× the world's share of Life Sciences.

Life Sciences: 11 fractional works · 53.7% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 29.2% of its workMolecular Biology: 5 fractional works · 26.0% of its workBiotechnology: 0 fractional works · 1.6% of its workGenetics: 0 fractional works · 1.1% of its workCancer Research: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 24.5% of its workImmunology: 5 fractional works · 24.5% of its workHealth Sciences: 8 fractional works · 36.6% of its workMedicine: 8 fractional works · 36.6% of its workOncology: 4 fractional works · 18.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 6.5% of its workEpidemiology: 1 fractional works · 3.0% of its workInfectious Diseases: 0 fractional works · 2.4% of its workOphthalmology: 0 fractional works · 1.6% of its workHematology: 0 fractional works · 1.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.4% of its workPhysical Sciences: 2 fractional works · 7.3% of its workEngineering: 1 fractional works · 3.3% of its workBiomedical Engineering: 1 fractional works · 3.3% of its workChemistry: 0 fractional works · 2.4% of its workOrganic Chemistry: 0 fractional works · 2.4% of its workMaterials Science: 0 fractional works · 1.6% of its workMaterials Chemistry: 0 fractional works · 1.6% of its workSocial Sciences: 0 fractional works · 2.4% of its workArts and Humanities: 0 fractional works · 2.4% of its workHistory: 0 fractional works · 0.8% of its workLiterature and Literary Theory: 0 fractional works · 0.8% of its workReligious studies: 0 fractional works · 0.8% of its workALL ITS WORKOncoImmune(United States)21fractional works, 2022-now
Life Sciences54%Physical Sciences7%Health Sciences37%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 7 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology629.2%
    2. Immunology and Microbiology524.5%
    1. Medicine836.6%
    1. Engineering13.3%
    2. Chemistry02.4%
    3. Materials Science01.6%
    1. Arts and Humanities02.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.47× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 24.36× its world share, 5 worksImmunology and Micro…Chemistry: 1.55× its world share, 0 worksChemistryEngineering: 0.22× its world share, 1 worksEngineeringMaterials Science: 0.46× its world share, 0 worksMaterials ScienceMedicine: 1.90× its world share, 8 worksMedicineArts and Humanities: 0.84× its world share, 0 worksArts and Humanities1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology24.36×5 works
  2. Biochemistry, Genetics and Molecular Biology5.47×6 works
  3. Medicine1.90×8 works
  4. Chemistry1.55×0 works
  5. Arts and Humanities0.84×0 works
  6. Materials Science0.46×0 works
  7. Engineering0.22×1 works

Who are the top researchers at OncoImmune (United States)?

Ranked on the quality score, Akira Komoriya, Laura J. Peek and Beverly Z. Packard lead among researchers whose main affiliation is OncoImmune (United States).

  1. 1 Akira Komoriya United States · #257,809 worldwide 7.3k citations · 67 works
  2. 2 Laura J. Peek United States · #1,190,505 worldwide 2.1k citations · 44 works
  3. 3 Beverly Z. Packard United States · #1,592,349 worldwide 2.3k citations · 48 works
All ranked researchers at OncoImmune (United States)

What are the most cited papers from OncoImmune (United States)?

The most cited paper from OncoImmune (United States) is "Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control" (Stephen A. Migueles et al., 2008), with 612 citations. Next come "A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy" (251) and "Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice" (244).

Most cited papers
#PaperReleasedCitations
1 Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control Stephen A. Migueles et al. · Immunity Open access Dec 2008 612
2 A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy Xuexiang Du, Fei Tang, Mingyue Liu et al. · Cell Research Open access 22 Feb 2018 251
3 Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice James R. Jett, Laura J. Peek, Lynn Fredericks et al. · Lung Cancer Open access 22 Oct 2013 244
4 High‐throughput quantitative analysis of HIV‐1 and SIV‐specific ADCC‐mediating antibody responses Justin Pollara, Lydia Hart, Faraha Brewer et al. · Cytometry Part A Open access 6 Jul 2011 208
5 EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays Caroline J Chapman, Graham F. Healey, Andrea D. Murray et al. · Tumor Biology Open access 10 Apr 2012 191
All 95 most cited papers, with filters and sorting

Which keywords describe research at OncoImmune (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Immunotherapy, Innate Immunity, Antigen Presentation, Dendritic Cells, Tumor Antigen and Vaccine Adjuvants.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Cancer Immunotherapy4▲ 127×2 topics
  2. Immunity3▲ 38×3 topics
  3. Immunotherapy3▲ 19×5 topics
  4. Innate Immunity3▲ 39×3 topics
  5. Antigen Presentation2▲ 131×2 topics
  6. Dendritic Cells2▲ 124×2 topics
  7. Tumor Antigen2▲ 180×1 topic
  8. Vaccine Adjuvants2▲ 180×1 topic
  9. Tumor Regression2▲ 91×2 topics
  10. Nanoparticles2▲ 7.7×2 topics
  11. Lymphoma2▲ 56×2 topics
  12. CAR T Cells2▲ 117×1 topic
  13. Chimeric Antigen Receptor2▲ 117×1 topic
  14. Gene Therapy2▲ 46×3 topics
  15. Tumor Microenvironment2▲ 19×3 topics
  16. Cancer Therapy2▲ 13×5 topics
  17. Immune Checkpoint Blockade2▲ 67×1 topic
  18. PD-1 and PD-L12▲ 67×1 topic
  19. DNA nanotechnology1▲ 56×1 topic
  20. RNA Interference1▲ 79×1 topic
  21. Self-Assembly1▲ 20×1 topic
  22. siRNA Delivery1▲ 113×1 topic
  23. Glycosylation1▲ 52×2 topics
  24. Inflammation1▲ 2.7×7 topics
  25. Cancer1▲ 4.0×6 topics
  26. Fc Receptors1▲ 89×1 topic
  27. Therapeutic Antibodies1▲ 70×1 topic
  28. Tumor Targeting1▲ 26×2 topics

Which research topics does OncoImmune (United States) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Advanced biosensing and bioanalysis techniques.

Immunotherapy and Immune Responses: 2 fractional worksCAR-T cell therapy research: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksAdvanced biosensing and …1Advanced biosensing and bioanalysis techniques: 1 fractional worksRNA Interference and Gene Delivery: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksDNA and Nucleic Acid Che…1DNA and Nucleic Acid Chemistry: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional worksUbiquitin and proteasome pathways: 1 fractional works
ImmunologyOncologyMolecular BiologyRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 DNA and Nucleic Acid Chemistry Molecular Biology 1 works
  8. 8 Immune Cell Function and Interaction Immunology 1 works
  9. 9 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  10. 10 Ubiquitin and proteasome pathways Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.9%not open62.1%

World: 40% of research is openly available.

with international co-authors15.2%domestic only84.8%

World: 18% is written across borders.

How has OncoImmune (United States)'s research output changed?

Output in 2022-2025 was 24% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is OncoImmune (United States) as a percentage of every work published that year, 0.000096% in 2024.

still counting0.00020%0.00040%0.00060%OncoImmune (United States)0.00012% in 2025200020102020

Fractional works of OncoImmune (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rockville

All research institutions in Rockville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about OncoImmune (United States). Posts are plain text and can be reported.